Scarica l'app Stockscreener
0.94
4.09%
0.0369
Dopo l'orario di chiusura:
.94
Precedente Chiudi:
$0.9031
Aprire:
$0.9061
Volume 24 ore:
74,320
Relative Volume:
0.33
Capitalizzazione di mercato:
$4.48M
Reddito:
-
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-0.1962
EPS:
-4.79
Flusso di cassa netto:
$-16.95M
1 W Prestazione:
-2.50%
1M Prestazione:
+14.63%
6M Prestazione:
+59.86%
1 anno Prestazione:
+497.96%
Intervallo 1D:
$0.9004
$0.9402
Intervallo di 1 settimana:
$0.8803
$0.9645
Portata 52W:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Nome
Matinas Biopharma Holdings Inc
Settore
Industria
Telefono
908-443-1860
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Confronta MTNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.94 | 4.48M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Ripresa | Piper Sandler | Overweight |
| 2020-01-27 | Iniziato | Piper Sandler | Overweight |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2020-01-09 | Iniziato | Aegis Capital | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media
Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World
Matinas Biopharma (NYSE:MTNB) versus Marker Therapeutics (NASDAQ:MRKR) Head to Head Review - Defense World
Matinas BioPharma amends bylaws, updates on officer agreements By Investing.com - Investing.com Canada
Matinas BioPharma Amends Bylaws and Sets Annual Meeting - TipRanks
Matinas BioPharma amends bylaws, updates on officer agreements - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Matinas Biopharma (NYSE:MTNB) Shares Down 2.6% – Here’s What Happened - Defense World
MTNB stock touches 52-week low at $0.48 amid sharp annual decline - Investing.com Australia
MTNB stock touches 52-week low at $0.48 amid sharp annual decline By Investing.com - Investing.com South Africa
Matinas BioPharma secures shareholder nods on key proposals By Investing.com - Investing.com Australia
Matinas BioPharma secures shareholder nods on key proposals - Investing.com
Matinas Biopharma Delays 10-K Filing - TipRanks
Matinas Biopharma (NYSE:MTNB) Shares Down 6.6% – Should You Sell? - Defense World
Matinas BioPharma Chairman Eric Ende Resigns -March 17, 2025 at 05:08 am EDT - MarketScreener
Matinas BioPharma announces board chairman’s departure By Investing.com - Investing.com Australia
Matinas BioPharma announces board chairman’s departure - Investing.com
Matinas Biopharma Holdings Eric Ende Resigns As Chairman Of Matinas Biopharma -March 14, 2025 at 05:48 pm EDT - Marketscreener.com
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Silicon Valley - Financial Content
Matinas Biopharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market SessionArtiva Biotherapeutics (NASDAQ:ARTV) - Benzinga
Matinas Biopharma Announces Agreement For The Acquisition Of Preferred Stock And Appointment Of Dr. Robin L. Smith To The Board Of Directors - Marketscreener.com
Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire
Biotech Deal Alert: Matinas BioPharma Lands Critical $3.3M Investment While Strengthening Leadership - StockTitan
Matinas BioPharma announces board member retirement - MSN
Matinas BioPharma announces board member retirement By Investing.com - Investing.com South Africa
Matinas BioPharma Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Matinas Biopharma Appoints Evelyn D’An as Director and Audit Committee Chair - Armenian Reporter
Matinas BioPharma Appoints Evelyn D’An to Board - citybiz
Matinas BioPharma Holdings, Inc. Appoints Evelyn D?An to Board of Directors as an Independent Director and Chair of the Audit Committee - Marketscreener.com
Matinas Biopharma Appoints Evelyn D'An To Board Of Directors As Audit Committee Chair - Marketscreener.com
Matinas BioPharma Appoints Evelyn D'An to Board of Directors as Audit Committee Chair - The Manila Times
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair - GlobeNewswire
Matinas BioPharma announces board member resignation - MSN
Matinas BioPharma announces board member resignation By Investing.com - Investing.com South Africa
Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):